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Abstract At present the pharmaceutical academia and industries are focusing 
on the use of natural materials and resources for development of pharmaceutical 
product. Due to advances in drug delivery technology, currently, excipients are 
included in novel dosage forms to fulfill specific functions. Various natural 
polymers are widely being studied as a potential carrier material for site 
specific drug delivery because of its non-toxic and biocompatible in nature. 
Natural polymers (polysaccharides) have been investigated for drug delivery 
applications as well as in biomedical fields. Modified polymer or synthetic 
polymers have found its application as a support material for cell culture, tissue 
engineering and gene delivery. Recent trends towards use of natural products 
or plant based products demand the replacement of synthetic additives with 
natural ones. These natural materials have many advantages over synthetic 
ones as they are biodegradable, chemically inert, less expensive, nontoxic and 
widely available. This review provides an overview of the different modified 
polymer derivatives and their applications with special consideration being put 
on biomedical engineering and controlled drug delivery.
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1. INTRODUCTION
In recent years, polymers those are derived from plant origin have evoked 
tremendous interest because of their diverse pharmaceutical applications such 
as diluent, disintegrant, binder in tablets; thickeners in oral liquids; protective 
colloids in suspensions; binder and gelling agents in gels; and bases in 
suppository. They are also used in textiles, cosmetics, paints and paper making 





These natural gums and mucilages are preferred over the synthetic ones 
because they are cheap, biocompatible, nontoxic, chemically inert, soothing 
action, availability, nonirritant nature of the excipients  and easily available 
than the synthetic ones. Demand for these substances is increasing and new 
sources are being developed. Carbohydrate polymers are widely used in 
recent years in pharmaceutical applications and biomedical due to their 
biodegradability and biocompatibility. The polysaccharides stand for one 
of the most abundant industrial raw materials and have been the subject of 
intensive research due to their sustainability, bio-safety and bio degradability. 
The natural gums are product obtained as a result of metabolic mechanisms 
of plants. These gums are either water soluble or absorb water to form a 
viscous solution. Natural gums are easily available, economic and found 
useful as tablet binder. For example neem gum, khaya gum, mango gum 
etc.  Neem (A. Indica, A. Juss) is perhaps the most useful and very beneficial 
traditional medicinal plant in India. Gum is obtained from the incised 
trunks of local A. Indica plant (belongs to family Meliaceae). Khaya gum is 
obtained from incised trunk of K. grandifolia (belongs to family Meliaceae). 
The mango tree (M. Indica, Family: Anacardiaceae)is also natural polymer 
which is used in pharmaceutical applications. Each and every part of the 
tree (bark, leaves, root, kernel, seed and fruit) serves a certain purpose, 
such as diuretic, astringent, aphthous, stomatitis, diabetes, scabies, asthma, 
urethritis, dysentery and other parasitic skin diseases. Hupu gum is the dried 
gummy exudate obtained from the deciduous tree of C. religiosum, (family 
Cochlospermaceae). These gums have been shown to possess binding 
properties. Synthetic polymers such as Captisol is derivative of anionic 
-cyclodextrin with a sodium sulfonate salt separated from the hydrophobic 
cavity by a butyl ether spacer group, which is used as polymer for the 
improving bioavailability, solubility and  stability of the drugs. Soluplusis 
a polyethylene glycol, polyvinyl acetate and polyvinylcaprolactam based 
graft copolymer. It is a novel excipient which is used as a carrier matrix and 




Neem (A. Indica, A. Juss) is perhaps the most useful and very beneficial 
traditional medicinal plant in India. (19). Innumerable part of the neem 
tree(gum, roots, flower, leaf etc.) has some medicinal property and is thus 







commercially credulous. This is well known in India for more than 2000 years 
having a wide spectrum of biological activity.
2.1.1 Gum Extraction 
The Neem gum is collected then hydrated in a sufficient amount of distilled 
water with sporadic stirring and irrelevant materials were removed by filtering 
using a Buchner funnel under negative pressure. The gum is precipitated with 
95% ethanol from the filtered slurry; the precipitated gum is then filtered, 
washed with acetone for several times and dried in a hot air oven at 30°C for 
96 h before milling and sieving with a mesh No. 60 (250 µm) and then dried 
fine powder is formed and stored in an amber colored bottle until needed.(1).
2.1.2 Chemical Structure of Neem Gum
Figure 1: Structure of neem active constituents.
2.1.3 Biological Activities of Various Part of Neem 
Large number of compounds has been isolated from various part of neem; a 
few of them have been studied for biological activity (Table 1). For examples:
2.1.4 Medicinal Uses of Various Part of Neem
2.1.5 Other Uses of Neem
(i) Antifungal activity: The leaves contain nimbidol and edunin, which have 





Table 2: Enlisted medicinal uses of various parts of Neem Plant.
S.No Parts Medicinal Uses
1. Flower Elimination of intestinal worms and phlegm, bile suppression
2. Fruit Urinary disorder, wounds and leprosy, relieves piles, intestinal worms, diabetes
3. Seed Pulp Intestinal worms and leprosy
4. Gum Scabies, wounds, ulcers, effective against skin disease like ringworms
5. Leaf Leprosy, epistaxis, intestinal worms, eye problems, anorexia, skin ulcers, bioliosness
6. Bark Analgesic, antipyretic
7. Twing Asthma, piles, phantom tumour, diabetes, spermatorrhoea, relieves cough, intestinal worms
8. Oil Intestinal worms & leprosy
9. Root, Bark, Flower 
and Fruits 
Billiary, burning sensation, skin ulcer, blood 
morbidity
Table 1: Various compounds from various parts of Neem plant and their 
biological activity.
S.No. Compounds Source Biological Activity
1 Nimbin Seed Oil Spermicidal
2 Nimbidine Seed Oil
Antifungal, Antibacterial,  
Anti-inflammatory, 
Antipyretic, Antiarthritic, 
Hypoglyceamic, Spermecidal,  
Diuretic
3 Azadirachtin Seed Oil Antimalarial
4 Cyclic Tetrasulphide Leaf Antifungal
5 Mahmoodin Seed Oil Antibacterial
6 Margolone Bark Antibacterial
7 Gallic acid &  Catechin Bark
Anti-inflammatory,  
Immunomodulatory
8 PolysaccrideG1A, G1B Bark Antitumour
9 Nimbolide Seed Oil Antibacterial, Antimalarial
10 Gedunin Seed Oil Antimalarial, Antifungal
11. NB-2 Peptidoglucan Bark Immunomodulatory







in the leaves are perilous to fungus. By inhibiting the growth of Tinea 
rubrum, Nimbidin also demonstrated anti fungal activity.
(ii) Antibacterial activity: Nimbidin can completely inhibit the growth 
of Mycobacterium tuberculosis thereby showed bactericidal activity. 
The neem oil along with the leaves reveal antibacterial and antiseptic 
benefits. The paste form of neem leaves are mostly used to treat 
manydifferent skin conditions for example, eczema, rashes, psoriasis 
and acne. 
(iii) Antiviral activity: Aqueous extracts from the leaves has shown antiviral 
properties and offers antiviral activity against vaccinia virus, and 
measles virus in vitro.
(iv) Antimalarial activity: Seeds and leaves extracts are effective against 
both chloroquin-resistant and sensitive strain malarial parasites. 
Nimbolideinhibits the Plasmodium falciparm which illustrate 
antimalarial activity.
(v) Reproductive health: Neem reduces fertility in both men and women 
without affecting sexual performance or libido. Neem is also used as a 
vaginal suppository because of spermicide properties and could prevent 
sexually transmitted infections.
(vi) Arthritis: Nimbin is an anti-inflammatory that is the main reason of 
using neem to cure arthritis. Polysaccharides present in the neem, 
reduces the inflammation and pain.
(vii) Skin health: Neem also removes the little parasites that cause scabies. 
According to ayurveda practice, neem oil is used topically as a therapy 
for psoriasis and eczema.
(viii) Some other uses of neem gum such as antifertility, antitumour, 
antiglyceamic etc. (23).
2.1.6 Pharmaceutical Applications of Neem gum
(i) Suspending agent, Thickening agent, Adhesive agent, Sustained release 
agent
(ii) Binding agent (binder in tablets): Various synthetic, semi-synthetic and 
natural substances such as celluloses, starches, and gums have been 
employed in pharmaceutical tablet formulations as binders. Gum is an 
example of hydrophilic substance employed in pharmaceutical solid 
dosage forms mainly as binders and directly compressible excipients. 
A research report assessed the activity of neem gum as a binder in a 
paracetamol tablet dosage form. Inclusion of neem gum improved the 
balance between binding and disintegration properties of paracetamol 





(iii) Coating agent: Neem gum did not affect the drug release from the coated 
and the mechanical properties tablet adversely. The% LOD and coating 
uniformity of neem gum coated tablets ensured good finish. Neem gum 
is accomplished natural, cheap, biodegradable and ecofriendly film 
former for aqueous filmcoating of tablets, moisture sensitive drug or 
particularly for bitter taste. (15).
2.4 MANGO GUM 
Mango gum is a dried gummy exudate polysaccharide obtained from 
the bark of M. indica, (family Anacardiaceae) [Madhuri et al. (2014)]. 
Mangiferin, being a polyphenolic antioxidant and a glucosyl xanthone, has 
strong immunomodulation, hypotensive, antioxidant, anti-lipid peroxidation, 
cardiotonic, wound healing, antidegenerative and antidiabetic activities. Ripe 
mango fruit is considered to be stimulating and freshening. The juice is used 
in heat stroke and recuperative tonic. The seeds are used as an astringent and 
in the treatment of asthma. Fumes from the burning leaves are inhaled which 
gives relief from infections of the throat and hiccups (27, 18). The bark is used 
as astringent and also used in diphtheria and rheumatism, and it is believed to 
possess a tonic action on mucus membrane. The gum is used for scabiesand 
dressings for cracked feet. Most parts of the mango tree are used for medicinal 
purpose and the bark also contains tannins, which are used for the purpose of 
dyeing (25).
2.2.1 Purification of Mango Gum from Mango Tree
The mango gum was dried and hydrated in distilled water for one day with 
continuous stirring; irrelevant materials were removed by straining through 
muslin cloth. The gum was precipitated with 95% ethanol from the filtered 
slurry; the precipitated gum was then filtered and dried on water bath at 50°C. 
The dried gum was milled using a laboratory blender and stored in tightly 
closed container (27, 18).
2.2.2 Chemical Nature of Mango or Mango Gum
Mangiferin contains xanthone glycoside major bio-active constituent, 
tannins, isomangiferin & gallic acid derivatives. Gums and mucilages are 
polysaccharides and they contain sugars. The bark is reported to contain 
protocatechic acid, γ-aminobutyric acid, mangiferin, catechin, alanine, glycine, 
kinic acid, shikmic acid and the tetracyclic triterpenoids. Indicoside A and B, 
manghopanal, manglupenone, mangocoumarin, mangoleanone, cycloartan-
3β-30-diol and derivatives, mangsterol and mangiferolic acid methyl ester and 
others have been isolated from stem bark of mango. Root of mango contains 







the chromones, 3-methoxy-2-(4’-methyl benzoyl)-chromone and  3-hydroxy-
2-(4’-methylbenzoyl)-chromone and the leaf and flower yield an essential oil 
containing humulene and elemene. The fruit pulp contains vitamins A and C, 
xanthophylls, β-carotene.
2.2.3 Pharmaceutical Uses of Mango Gum
Mango gum resin is collected from the incised trunk of M. indica. Various 
parts of plant are used as a dentrifrice, tonic, astringent, diaphoretic, 
stomachic, antiseptic, laxative and diuretic and to treat diarrhea, anaemia, 
asthma, bronchitis, cough, hypertension, insomnia, toothache, leucorrhoea, 
haemorrhage and piles. All parts are used to treat abscesses, tumour, broken 
horn, rabid dog or jackal bite, datura poisoning, snakebite, stings, heat stroke, 
miscarriage, anthrax, blisters, wounds in the mouth, glossitis, indigestion, 
bacillosis, bloody dysentery, liver disorders, excessive urination, tetanus and 
asthma (27).
2.2.4 Applications of Mango or Mango Gum
(i) Anti-diabetic: A 50% ethanolic extract of the leaves produced 
hypoglycemic effect at a dose of 250 mg/kg. The effect of the aqueous 
extract of the leaves of M. indica on blood glucose level in glucose - 
induced hyperglycaemic, normoglycaemic, and streptozotocin (STZ)-
induced diabetic rats has been assessed. The results showed the aqueous 
extract of the leaves of MI possess hypoglycaemic activity.
(ii) Antiviral activity: In vitro studies give against Herpes simplex virus 
type 2; it inhibits the late event in HSV-2 replication. But it does not 
directly inactivate HSV-2. In vitro mangiferin also inhibit HSV-1 virus 
replication within.





(iii) Anthelmintic and anti-allergenic activity: The study of mangiferin 
isolated from extract of M. indica was carried out to find out anti-allergic 
properties. This natural extract of M. indica could be successfully used 
in the treatment of allergic disorders.
(iv) Antiparasitic activity:In a neonatal mouse model, mangiferin showed 
similar inhibitory activity at 100 mg/kg Cryptosporidium parvum than 
the same dose (100 mg/kg) of an active drug (paromomycin).
(v) Antibone resorption: Four water extracts of Kampo formulae were 
screened for their inhibitory effect on bone resorption induced by 
parathyroid hormone in organ culture of neonatal mouse parietal bones. 
Mangiferin isolated and tested in vitro showed a significant inhibitory 
effect on this model.
(vi) Anti-tumor-anti-HIV: Significant cytotoxic activities have been 
established by the stem bark extract of mango against the breast 
cancer cell as well as against a colon cancer cell and a renal cancer 
cell line. In vitro, Mangiferin dose- and time-dependently inhibited the 
proliferation of K562 leukemia cells and induced apoptosis in K563 
cells line. These results recommend that mangiferin has a potential as a 
naturally-occurring chemopreventive agent.
(vii) Antispasmodial and antipyretic activity: The stem bark extract 
was evaluated for antiplasmodial activity against Plasmodium yoelii 
nigeriensis and antipyretic activity.  A reduction in yeast-induced 
hyperpyrexia was also produced by the extract of M. indica.
(viii) Immunomodulatory: Immunomodulatory activity of alcoholic extract 
of stem bark of M. indica was investigated in mice models. Mangiferin 
mediates the down-regulation of NF-xB, suppresses NF-xB activation 
induced by inflammatory agents, increases the intracellular glutathione 
(GSH) levels, including tumor nuclear factor (TNF) and potentiates 
chemotherapeutic agent-mediated cell death; this suggests a possible 
role in combination therapy for cancer.
(ix) Anti-diarrhoeal: The potential anti-diarrhoeal activity of methanolic 
and aqueous extracts of seeds of MI has been evaluated which was 
induced by castor oil and magnesium sulphate in mice models and 
results demonstrate that the extracts of MI have significant anti-
diarrhoeal activity and part of the activity may be attributed to its effect 
on intestinal transit.
(x) Anti-bacterial and antifungal activity: In vitro agar diffusion technique 
in mangiferin showed activity against 7 bacterial species, Salmonella 
agona, Bacillus pumilus, B. cereus, Staphylococcus aureus, S. 
citreus, Klebsiella pneumoniae, 1 yeast (Saccharomyces cerevisiae), 







Escherichia coli and 4 fungi (Thermoascus aurantiacus, Trichoderma 
reesei, Aspergillus flavus and A. fumigatus).
2.3 Hupu Gum
Hupu gum is the dried gummy exudate obtained from the deciduous tree of 
“Cochlospermum religiosum, Alston” (synonym Cochlospermum gossypium), 
(family Cochlospermaceae). Hupu gum tree is abundantly found in forests and 
hills of  Chittoor. Its applicability is reported for industries like paper, nicotine 
sprays, printing gum and in the preparations of lotions and pastes. Some 
investigation have been conducted on hupu gum as a potential food additive in 
food &nutria-tion industries. Basically it is a polymer of rhamnose, glucuronic 
acid, galacturonic acid, b-D galactopyranose, b-D-glucose, galactose, a-D-
glucose arabinose,  fructose and mannose with sugar linkage. The enhancement 
of dissolution profile of Pioglitazone HCl using modified Hupu gum as carriers 
by solid dispersion technique. It is reported that the swelling ability of the 
hupu gum improves dissolution rate of poorly water soluble drug (26, 24).
2.3.1 Chemical Nature of Hupu Gum 
Hupu gum is a naturally occurring polysaccharide derived as an exudate from 
the tree. Hupu gum is a polymer of galacturonic acid, b-D galactopyranose, 
rhamnose, a-D arabinose, mannose  and fructose with sugar linkage. Modified 
hupu gum were characterized for  swelling index, viscosity and water retention 
capacity. The modified hupu gum gives tremendous changes in structural 
bonding, crystallinity, cohesive and adhesive forces of attraction of drug, at 
different temperature, which help to lower the viscosity and swelling index and 
this reacts to increases water holding capacity which improves the wettability 
of drug and helps to dissolve the poorly water soluble drug (24).
2.3.2 Preparation of Modified Hupu Gum
Powdered hupu gum is placed in a porcelain bowl and subjected to heating 
in hot air oven for 140°C for 2 h. The prepared modified hupu gum is finally 
resieved (100 mesh) and stored in airtight container at 25°C. (24)
2.3.3 Application of Hupu Gum
a. To Enhance the Solubility of Drug Solid dispersion was prepared 
by co-grinding method using hupu gum and modifiesd hupu gum 
with pioglitazone HCl. The solubility of Pioglitazone HCl increases 
with hupu gum and significantly high with modified hupu gum. Hupu 





dissolution, whereas pioglitazone HCl-modified hupu gum particles 
dispersed rapidly. Hupu gum increases water holding capacity which 
improves the wettability of drug and helps to dissolve poorly water 
soluble drug (24).
b. Target Drug Delivery System: Hupu gum has been used as the drug 
delivery carrier. Solid dispersions of mefanimic acid with hupu gum were 
prepared by kneading method at different ratios. Hupu gum (HG) was 
used as plug. The solid dispersions have been used for the formulation 
of pulsin caps. Solid dispersions of mefenamic acid were filled in the 
bodies which were made insoluble by formaldehyde treatment. Sealing of 
body and cap were done using ethyl cellulose. Ethyl cellulose coating was 
employed to ensure the colon targeting of pulsin caps. The studies have 
clearly indicated that formulations were very effective to deliver the drug 
specifically to colon. (5).
c. To Enhance Mucoadhesive Property: The study was undertaken to assess 
the mucoadhesive property of hupu gum in design of mucoadhesive buccal 
patches using Propanolol Hcl as a model drug. Mucoadhesive strength 
measurement was conducted for formulation containing hupu gum with 
drug and show it good mucoadhesive property. (12).
3. SYNTHETIC EXCIPIETNS
3.1 Captisol
Captisol® is a patent protected, unique modified cyclodextrin, whose chemical 
structure was rationally designed to enable the creation of new products by 
significantly improving bioavailability, solubility, stability and dosing of active 
pharmaceutical ingredients (APIs). CAPTISOL is a derivative of anionic-
cyclodextrin with a sodium sulfonate salt separated from the hydrophobic 
cavity by a butyl ether spacer group. (30).
3.1.1 Chemical Nature of Captisol
Captisol is the trade name for modified cyclodextrin preparation. Scientists 
of the ‘Kansas University’invented and initially developed the Captisol. 
Captisolis a combination of polyanionic-cyclodextrin derivatives of a sodium 
sulfonate salt tethered to the lipophilic cavity by sulfobutyl ether (SBE) or a 
butyl ether group. The selection of Captisol was based upon evaluations of 
the mono, tetra and hepta-substituted preparations such as the cyclodextrin 
preparation with the most desirable safety profile and drug association 
properties (30).







3.1.2 Structure of Captisol: Structure of Captisol and site of action is 
shown in figure 3 and 4.
Figure 3: Structure of CaptisolFigure 4: Site of action.
3.1.3 Benefits of Captisol
(i) Product Development: Product development is a composite process for 
discovery and evaluation to develop and commercialize CAPTISOL 
provides an elegant solution to stability and solubility hurdles faced 
during each phase of the development process.
(ii) Solubilizer: Neutral, anionic and cationic drugs as well as small and 
large molecules, have been effectively complexed by Captisol. Aqueous 





solubility was increased by a factor of 10 to 25,000 depending drug 
upon the compound. In comparison to other solubilization technologies, 
product or traditional formulation system, the solubility and feasibility 
effectiveness of Captisol can be rapidly assessed with a few simple lab 
experiments.
(iii) Stabilizer: Captisol provides protected environment for the drug 
molecule in its lipophilic cavity while its hydrophilic surface provides 
good water solubility and stability. Interaction of the drug with 
CAPTISOL can reduce drug decomposition in the aqueous environment 
by protecting the labile region from the potential reactants.(10).
3.1.4 Applications of Captisol
a. Enhances drug solubility: Dissolution enhancement of antiepileptic 
drug carbamazepine was improved by forming inclusion complex using 
Captisol. The inclusion complex exhibited significantly higher in vitro 
dissolution profile as compared with pure carbamazepine powder. 
b. Enhances the drug stability: In aqueous solution stability of drugs can 
markedly improve on complexation with CAPTISOL. Enclosure of the drug 
in the cyclodextrin cavity can serve to reduce the rate of decomposition by 
‘hiding’ the reactive center. CAPTISOL minimize aggregation, preventing 
adsorption to containers and refolding which helps in stabilizing some 
protein and peptide formulations. Captisol decrease the aggregation of 
insulin and increase the bioavailability to 96%. It can also help to improve 
the physical stability. 
c. Effective Drug Delivery: Captisol may be applied in drug delivery in 
many ways. Pharmacokinetic results showed that drugs dissociate rapidly 
and quantitatively from their cyclodextrin complexes on dilution with 
tissue fluids. Chemical structure of Captisol was designed to maximize 
the safety of the material by minimizing the damaging effects produced 
by the parent cyclodextrin. Increased solubility and stability translate into 
enhancement of efficacy via increased dissolution rate or solubility in the 
lower GI, leading to greater and faster absorption, bioavailability and more 
rapid onset of action.
d. Safe Drug Carrier: Chemical structure of Captisol was designed to 
take advantage of the safety of the material by minimizing the damaging 
effects produced by the parent cyclodextrin. Captisol mainly targets the 
multi-billion dollar solubility fragment of the global drug delivery market. 
Captisol with advanced safety and excellent drug carrier property, makes 
it the standard solubility solution. For example anionic Sulfobutylether 
group was introduced to take advantage of the kidney’s ability to quickly 







excrete ionic compounds, hence minimizing the contact time between the 
kidney cells and the cyclodextrin.
3.2 SOLUPLUS
Various new active pharmaceutical ingredients having lipophilic nature, suffer 
from low bioavailability due to their low aqueous solubility and dissolution. 
Various approaches have been used like micronization, solubilization, 
complexation with polymer, salt formation, use of prodrug etc. but all these 
approaches having some limitations. The solubility can be overcome by 
soluplus using as a solubility enhancer. (16). Soluplus; a polyethylene glycol, 
polyvinyl acetate and polyvinylcaprolactame-based graft copolymer (PVAc- 
PVCap- PEG), a new polymer with amphiphilic properties is the novel excipient 
which is used as a carrier matrix and solublizer. Soluplus shows excellent 
solubilizing properties for BCS class II substances (29). The dissolution of 
poorly soluble drugs in aqueous media can be highly improved by the use of 
solid solutions with soluplus. The various techniques can be used for soluplus 
are Spray drying method, Solvent evaporation, Melting method, preparation 
of physical mixtures. Soluplus is a novel polymer specially designed for the 
fourth generation solid solutions towards dissolution enhancement. (9). 
3.2.1 Chemical Structure of Soluplus
Figure 5: Structure of Soluplus.
3.2.2 Application
a. Enhance Solubility: The drug in presence of soluplus lead to improved 
wettability anddispersibility, as well as decrease in the crystalline state 
and increase of the amorphous fraction. Soluplus could be regarded as 





rate of poorly water soluble drugs. With its outstanding solubilisation 
properties, Soluplus is designed to specifically dissolve poorly soluble 
active pharmaceutical ingredients (APIs).
b. Excellent capability to form solid solutions: Soluplus exhibited superior 
performance in forming solid solutions, especially in hot melt extrusion 
processes. ME is an excellent technique for the preparation of  solid 
dispersions as it has several advantages over other technique such as 
industrial feasibility, organic solvent free technology, high drug loading, 
less number of unit operations, anhydrous processing of moisture sensitive 
drug. 
3.2.3 Methods Used with Soluplus
(i) Hot Melt Extrusion Method: The excellent extrudability and high 
flowability of Soluplus make it superior in hot melt extrusion. Soluplus 
shows advanced performance in forming solid solutions, especially in hot 
melt extrusion processes. Soluplus is not an adequate to solid solutions 
formed via hot melt-extrusion, but can be used as a matrix former in spray 
drying processes (6,13).
(ii) Solid Dispersion Method: The solid dispersion of various poorly water 
soluble drugs with Soluplus was prepared, such as soluplus and PEG 4000 
was dissolved in methanol to which poorly water soluble drug was added 
with stirring, solvent was evaporated and the solid dispersion powder of 
drug and polymer was obtained (20).
(iii) Spray Drying Method: The dispersions were prepared by spray drying 
method. The spray drying was performed with various conditions such as 
inlet temperature, outlet temperature, and solution flow rate. The spray 
dried samples were stored in a desiccator. (8, 3). 
(iv) Solvent Evaporation Method: The solid dispersion of various poorly 
water soluble drugs with Soluplus was prepared by solvent evaporation 
method. The drug and soluplus dissolved in solvent (methanol) and the 
solvent evaporated under pressure using the rotary evaporator and the 
residue dried under vacuum. (30).
3.2.4 Uses
a. Solubility Enhancer: Soluplus is an novel excipient that enables new 
levels of bioavailability and solubility for poorly soluble active ingredients. 
The polymer used in various different ways with different drugs to 
significantly improve solubility and bioavailability (20, 14).







b. Binding Agent: The soluplus also used as a binding agent, due to this 
property the drug with soluplus can also be compressed into tablet. Its 
excellent ability to form solid solutions and outstanding solubilization 
capabilities, combined in one molecule, distinguish soluplus from other 
molecules that are used to form solid solutions. Soluplus is used as a 
binding agent in a wet granulation or a dry binder in direct compression. 
c. Enhance Bioavailability: Soluplus can increase the bioavailability of 
poorly water soluble drugs. Solid solutions were prepared with Itraconazol 
with soluplus and fenofibrate with soluplus. The solid solution makes the 
active pharmaceutical ingredient (API) available in a dissolved state, the 
result showed improve bioavailability once in the body (5).
d. Spray Drying Agent: Soluplus is not limited to solid solutions formed via 
hot melt-extrusion, but can also be used as a matrix former in spray drying 
Table 3: Research reports on various drugs using Soluplus as a carrier and the 
method used.
S.no. Drug Polymer Preparation Technique Temp(In-Out)
1. Lafutidine Soluplus Hot melt extrusion 84




4. Itraconazol Soluplus, Freeze Dry Method 140-160
5. Dronedaron HCL Soluplus Hot meltExtrusion 150




8. Valsartan Soluplus Hot melt extrusion 115-120
9. AtorvastatinCalcium Soluplus Spray drying
65-80 & 
50-60











processes. Soluplus can be used for spray drying of organic solutions. 
(9).
CONCLUSION
The low aqueous solubility of drug molecules is the limiting factor for their 
dissolution as well as bioavailability. Various novel excipients have been 
recognized, synthesized to overcome this problem. Now a days main research 
is on the development and identification of novel excipients whether natural 
or synthetic (Coprocessed, high functionality excipients). Current review 
has given a highlight about neem gum, hupu gum and mango gum; their use 
in formulation development as well as therapeutic benefits. Soluplus and 
captisol has also been discussed with their various benefits in drug product 
development of poorly aqueous soluble drugs. The gums and synthetic carriers 
has been explored as efficient solubility enhancers as evidenced with several 
researchers. 
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